American Journal of Kidney Diseases
Volume 53, Issue 6 , Pages 1014-1023 , June 2009

Association of Body Mass Index With Decline in Residual Kidney Function After Initiation of Dialysis

  • Christiane Drechsler, MD

      Affiliations

    • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    • Corresponding Author InformationAddress correspondence to Christiane Drechsler, MD, Leiden University Medical Center, Department of Clinical Epidemiology, PO Box 9600, 2300 RC Leiden, The Netherlands
    • ,
  • Renée de Mutsert, MSc

      Affiliations

    • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Diana C. Grootendorst, PhD

      Affiliations

    • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Elisabeth W. Boeschoten, MD, PhD

      Affiliations

    • Hans Mak Institute, Naarden, The Netherlands
    • ,
  • Raymond T. Krediet, MD, PhD

      Affiliations

    • Department of Nephrology, Amsterdam Medical Center, Amsterdam, The Netherlands
    • ,
  • Saskia le Cessie, PhD

      Affiliations

    • Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Christoph Wanner, MD

      Affiliations

    • Divison of Nephrology, University of Würzburg, Würzburg, Germany
    • ,
  • Friedo W. Dekker, PhD

      Affiliations

    • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • NECOSAD Study Group

Received 16 July 2008 ,Accepted 11 November 2008.

References 

  1. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA Study. J Am Soc Nephrol. 2001;12:2158–2162
  2. Maiorca R, Brunori G, Zubani R, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients (A longitudinal study). Nephrol Dial Transplant. 1995;10:2295–2305
  3. Rocco M, Soucie JM, Pastan S, McClellan WM. Peritoneal dialysis adequacy and risk of death. Kidney Int. 2000;58:446–457
  4. Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis. 2001;38:85–90
  5. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis. 2003;41:1293–1302
  6. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004;15:1061–1070
  7. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17:1695–1702
  8. Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis. 2008;52:39–48
  9. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–850
  10. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–880
  11. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: Are men more vulnerable?. Am J Kidney Dis. 2006;47:396–405
  12. Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis. 2008;52:29–38
  13. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–28
  14. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–1876
  15. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817–F822
  16. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol. 2003;14:1480–1486
  17. D'Agati VD, Markowitz GS. Supersized kidneys: Lessons from the preclinical obese kidney. Kidney Int. 2008;73:909–910
  18. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int. 2001;59:1498–1509
  19. de Mutsert R, Snijder MB, van der Sman-de Beer, et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol. 2007;18:967–974
  20. Dwyer JT, Larive B, Leung J, et al. Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study?. Kidney Int. 2005;68:1766–1776
  21. Pifer TB, McCullough KP, Port FK, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int. 2002;62:2238–2245
  22. Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int. 2003;64:1838–1844
  23. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–398
  24. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis. 2003;42:864–881
  25. Kalantar-Zadeh K, Balakrishnan VS. The kidney disease wasting: Inflammation, oxidative stress, and diet-gene interaction. Hemodial Int. 2006;10:315–325
  26. Garg AX, Blake PG, Clark WF, Clase CM, Haynes RB, Moist LM. Association between renal insufficiency and malnutrition in older adults: Results from the NHANES III. Kidney Int. 2001;60:1867–1874
  27. Kopple JD, Greene T, Chumlea WC, et al. Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD Study. Kidney Int. 2000;57:1688–1703
  28. ERA-EDTA Registry: ERA-EDTA Registry 2006 Annual Report. In: Amsterdam, The Netherlands: Academic Medical Center, Department of Medical Informatics; 2008;p. 126;Appendix 1-Grouping of primary renal diseases
  29. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet. 1993;341:415–418
  30. World Health Organization. Obesity: Preventing and Managing the Global Epidemic (Report of a WHO Consultation). Geneva, Switzerland: World Health Organization; 1999;
  31. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046–1053
  32. Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–564
  33. Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int. 2000;20:429–438
  34. Brown SC, O'Reilly PH. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: Evidence for a new gold standard. J Urol. 1991;146:675–679
  35. Gaspari F, Perico N, Remuzzi G. Measurement of glomerular filtration rate. Kidney Int Suppl. 1997;63:S151–S154
  36. Gaspari F, Perico N, Matalone M, et al. Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J Am Soc Nephrol. 1998;9:310–313
  37. Holliday MA, Heilbron D, al Uzri A, et al. Serial measurements of GFR in infants using the continuous iothalamate infusion technique (Southwest Pediatric Nephrology Study Group (SPNSG)). Kidney Int. 1993;43:893–898
  38. Rahn KH, Heidenreich S, Bruckner D. How to assess glomerular function and damage in humans. J Hypertens. 1999;17:309–317
  39. National Kidney Foundation. KDOQI: Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access. Am J Kidney Dis. 2006;48:S1–S322(suppl 1)
  40. Dombros N, Dratwa M, Feriani M, et al. European Best Practice Guidelines for peritoneal dialysis (2 The initiation of dialysis). Nephrol Dial Transplant. 2005;20:ix3–ix7(suppl 9)
  41. European Best Practice Guidelines Expert Group on Hemodialysis ERA: Section I (Measurement of renal function, when to refer and when to start dialysis). Nephrol Dial Transplant. 2002;17:S7–S15(suppl 7)
  42. Rosenberg DE, Jabbour SA, Goldstein BJ. Insulin resistance, diabetes and cardiovascular risk: Approaches to treatment. Diabetes Obes Metab. 2005;7:642–653
  43. Aneja A, El Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent Prog Horm Res. 2004;59:169–205
  44. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;51:1908–1919
  45. Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73:947–955
  46. Ritz E. Obesity and CKD: How to assess the risk?. Am J Kidney Dis. 2008;52:1–6
  47. Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH. Obesity-related glomerulopathy in China: A case series of 90 patients. Am J Kidney Dis. 2008;52:58–65
  48. Bosma RJ, Krikken JA, Homan van der Heide JJ, de Jong PE, Navis GJ. Obesity and renal hemodynamics. Contrib Nephrol. 2006;151:184–202
  49. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL. Obesity and target organ damage: The kidney. Int J Obes Relat Metab Disord. 2002;26:S21–S24(suppl 4)
  50. Lastra G, Manrique C, Sowers JR. Obesity, cardiometabolic syndrome, and chronic kidney disease: The weight of the evidence. Adv Chronic Kidney Dis. 2006;13:365–373
  51. Tomaszewski M, Charchar FJ, Maric C, et al. Glomerular hyperfiltration: A new marker of metabolic risk. Kidney Int. 2007;71:816–821
  52. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis. 2002;39:1–11
  53. Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002;324:127–137
  54. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102:42–47

 Originally published online as doi:10.1053/j.ajkd.2008.11.027 on February 17, 2009.

 A list of the NECOSAD study investigators appears at the end of this article.

PII: S0272-6386(09)00002-X

doi: 10.1053/j.ajkd.2008.11.027

American Journal of Kidney Diseases
Volume 53, Issue 6 , Pages 1014-1023 , June 2009

Article Tools

* Image Usage & Resolution